Xanthohumol prevents atherosclerosis by reducing arterial cholesterol content via CETP and apolipoprotein E in CETP-transgenic mice. [PDF]
BACKGROUND: Xanthohumol is expected to be a potent anti-atherosclerotic agent due to its inhibition of cholesteryl ester transfer protein (CETP). In this study, we hypothesized that xanthohumol prevents atherosclerosis in vivo and used CETP-transgenic ...
Hiroshi Hirata +6 more
doaj +2 more sources
CETP inhibitor evacetrapib enters mouse brain tissue [PDF]
High levels of plasma cholesterol, especially high levels of low-density lipoprotein cholesterol (LDL-C), have been associated with an increased risk of Alzheimer’s disease.
Jasmine Phénix +20 more
doaj +2 more sources
Targeting the CTBP1-CETP axis overcomes ferroptosis resistance in non-small cell lung cancer by altering lipid accumulation. [PDF]
CTBP1‐driven CETP activation orchestrates lipid accumulation to suppress MAPK‐dependent ferroptosis in non‐small cell lung cancer. Repurposing the clinical‐stage CETP inhibitor obicetrapib successfully overcomes this resistance in NSCLC patient‐derived organoids, highlighting a promising translational therapeutic strategy. Abstract Background Non‐small
Chen Y +11 more
europepmc +2 more sources
Free Fatty Acids Carried by Lipoproteins: Revisiting the Overlooked Cargo. [PDF]
ABSTRACT Free fatty acids (FFAs) are hydrophobic and therefore cannot enter the bloodstream at appreciable levels unless they are solubilized by FFA carriers. Albumin has been appreciated for years as the major FFA carrier, but it is not the only carrier.
Henderson GC, Buhman KK, Tomoo K.
europepmc +2 more sources
Hepatic APOF transcript levels correlate inversely with plasma TG and hepatic steatosis in humans. ApoF expression in mice promotes VLDL‐TG production and lipoprotein remnant clearance in mice. Abstract Background NAFLD affects nearly 25% of the global population. Cardiovascular disease (CVD) is the most common cause of death among patients with NAFLD,
Audrey Deprince +30 more
wiley +1 more source
Objective: To determines CETP mass and activity in rare disorders of HDL metabolism. Methods: Patients: Fasting plasma samples were obtained from two individuals with TD and from patients with LCAT deficiency, analphalipoproteinemia, Hepatic lipase ...
Sachs-Barrable, K +4 more
core +4 more sources
Effects of dalcetrapib in patients with a recent acute coronary syndrome [PDF]
In observational analyses, higher levels of high-density lipoprotein (HDL) cholesterol have been associated with a lower risk of coronary heart disease events.
Chaitman Bernard R. +107 more
core +1 more source
Genetic variants in lipid metabolism are independently associated with multiple features of the metabolic syndrome [PDF]
Background Our objective was to find single nucleotide polymorphisms (SNPs), within transcriptional pathways of glucose and lipid metabolism, which are related to multiple features of the metabolic syndrome (MetS).
Boer, J.M. +14 more
core +1 more source
CETP Deficiency and Concerns in CETP Inhibitor Development [PDF]
Although some CETP-lowering SNPs in the CETP gene are variably associated with improved clinical outcomes in patients with coronary artery disease (CAD), three low molecular weight oral CETP inhibitors (torcetrapib, dalcetrapib, and evacetrapib) have not
Akihiro Inazu +3 more
core +1 more source
On the incidence of Kelvin-Helmholtz instability for mass exchange process at the Earth’s magnetopause [PDF]
Due to the velocity shear imposed by the solar wind flowing around the magnetosphere, the magnetopause flanks are preferred regions for the development of a Kelvin-Helmholtz instability.
R. Smets +5 more
doaj +1 more source

